Close X
Attorney Spotlight

Find out how Gardner Bell's experience promoting financial and economic development initiatives both locally and abroad informs his role as an attorney. Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

H. Shine Chen Schattgen

Associate

Memphis
(901) 543-5924 TEL
(901) 543-5999 FAX

H. Shine Chen Schattgen

Associate

Memphis
(901) 543-5924 TEL
(901) 543-5999 FAX
Memphis
(901) 543-5924 TEL
(901) 543-5999 FAX

Shine Chen Schattgen counsels healthcare clients on a range of operational, regulatory and transactional matters related to clinical trials, physician contracts, healthcare information technology issues, mergers and acquisitions, HIPAA compliance and more. She has experience working with various healthcare institutions, including academic medical centers, hospitals and pharmaceutical and life sciences companies. 

Prior to joining Bass, Berry & Sims, Shine practiced in the Boston office of Ropes & Gray LLP where she advised healthcare clients on compliance issues. Shine earned her law degree from Duke University School of Law and a B.A. in neuroscience and political science from Wellesley College.

Memberships

Memphis Bar Association

American Health Lawyers Association (AHLA)

News

View More

Publications

View More

Media Mentions

View More

Additional Thought Leadership

Publications:

  • "European Union Negotiations Reach Agreement on New Clinical Trials Regulation," Bloomberg BNA Medical Research Law & Policy Report (February 2014)
  • "New EU Clinical Trials Regulation and its Interaction with Proposed EU Privacy Regulation and Proposed EMA Policy on Clinical Trials Data Transparency," Bloomberg BNA Medical Research Law & Policy Report (August 2014)


Accolades

Duke Journal of Constitutional Law and Public Policy – Managing Editor

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.